Broadly Neutralizing Antibodies [široce neutralizující protilátky]
- Terms
-
bnAbs
široce neutralizační protilátky
širokospektré protilátky
zkříženě neutralizující protilátky
-
bnAb
bnAbs
Broad Neutralizing Antibodies
Broad Neutralizing Antibody
Broad Spectrum Antibodies
Broadly Neutralizing Antibody
Cross-Neutralizing Antibodies
Cross-Neutralizing Antibody
Neutralizing antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent (e.g., HIV) by targeting several epitopes.
- DUI
- D000080908 MeSH Browser
- CUI
- M000648726
- Previous indexing
- Antibodies, Neutralizing (2009-2019)
- History note
- 2020
- Public note
- 2020
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects
- AN
- analysis
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CH
- chemistry
- CL
- classification
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology 1
- IP
- isolation & purification
- ME
- metabolism
- PD
- pharmacology
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- TU
- therapeutic use 1
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
2F5 monoclonal antibody Chemical MeSH Browser
2G12 monoclonal antibody Chemical MeSH Browser
3BNC117 antibody Chemical MeSH Browser
4Dm2m Chemical MeSH Browser
4E10 monoclonal antibody Chemical MeSH Browser
64Cu-DOTA-patritumab Chemical MeSH Browser
AR4A cross-neutralizing monoclonal antibody Chemical MeSH Browser
AVP-21D9 Chemical MeSH Browser
BIIB023 Chemical MeSH Browser
CF172 antibody Chemical MeSH Browser
Fletikumab Chemical MeSH Browser
PB-2452 Chemical MeSH Browser
VIS410 monoclonal antibody Chemical MeSH Browser
VRC01 monoclonal antibody Chemical MeSH Browser
actoxumab Chemical MeSH Browser
bezlotoxumab Chemical MeSH Browser
carlumab Chemical MeSH Browser
dusigitumab Chemical MeSH Browser
patritumab Chemical MeSH Browser
suvratoxumab Chemical MeSH Browser